Sebia opens its new affiliate in Canada

Paris, France, September 30, 2020_Sebia (Lisses, FRANCE) today announced the opening of its new affiliate, Sebia Diagnostics Canada Inc., which is set to formally open July 1, 2021. After a long-term distribution partnership with Somagen Diagnostics, which represented Sebia in the Canadian market for many years, the new Canadian Sebia team is excited to engage with customers directly to provide a world-class service and clinically differentiated innovations. The Sebia Canada team will be dedicated and ready to support laboratories across the country with sales, application specialists and after sales engineers.

Sebia Canada will also provide scientific services, technical and clinical education, and a “Knowledge Center” service to daily support and assist laboratories in interpreting Sebia laboratory tests. Sebia Canada is an important step forward in the development of the global company and is fully supported by its shareholders Caisse de dépôt et placement du Québec, CVC Capital Partners and Téthys Invest.

"Starting our direct operations in Canada will enable Sebia to successfully strengthen its undisputed leadership in multiple myeloma management, to continue its development in the diagnostic and monitoring of diabetes and propose other innovative biomarkers using our core technology.” says Jean-Marc CHERMETTE, CEO at Sebia.

Download the press release: